Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Journal of Medicinal Chemistry
|
October 1, 2004
Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein
Niklas K U Koehler, Chao-Yie Yang, Judith Varady, et al.
Journal of Medicinal Chemistry
|
November 3, 2010
4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6
Young Shin Cho, Maria Borland, Christopher Brain, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 5, 2008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
Sanjeev Shangary, Dongguang Qin, Donna McEachern, et al.
Journal of Medicinal Chemistry
|
March 20, 2018
Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity
Colin K Skepper, Robert J Moreau, Brent A Appleton, et al.
Chembiochem : a European Journal of Chemical Biology
|
April 18, 2023
Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors
Patrick Moon, Charlotte M Zammit, Qian Shao, et al.
Journal of the American Chemical Society
|
December 9, 2022
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4
Angel Gonzalez-Valero, Audrey G Reeves, Annika C S Page, et al.
Journal of Medicinal Chemistry
|
May 27, 2017
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC
Grazia Piizzi, David T Parker, Yunshan Peng, et al.
Journal of Medicinal Chemistry
|
March 3, 2018
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria
Robert J Moreau, Colin K Skepper, Brent A Appleton, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors
Young Shin Cho, Hayley Angove, Christopher Brain, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Journal of Medicinal Chemistry
|
October 1, 2004
Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein
Niklas K U Koehler, Chao-Yie Yang, Judith Varady, et al.
Journal of Medicinal Chemistry
|
November 3, 2010
4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6
Young Shin Cho, Maria Borland, Christopher Brain, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 5, 2008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
Sanjeev Shangary, Dongguang Qin, Donna McEachern, et al.
Journal of Medicinal Chemistry
|
March 20, 2018
Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity
Colin K Skepper, Robert J Moreau, Brent A Appleton, et al.
Chembiochem : a European Journal of Chemical Biology
|
April 18, 2023
Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors
Patrick Moon, Charlotte M Zammit, Qian Shao, et al.
Journal of the American Chemical Society
|
December 9, 2022
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4
Angel Gonzalez-Valero, Audrey G Reeves, Annika C S Page, et al.
Journal of Medicinal Chemistry
|
May 27, 2017
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC
Grazia Piizzi, David T Parker, Yunshan Peng, et al.
Journal of Medicinal Chemistry
|
March 3, 2018
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria
Robert J Moreau, Colin K Skepper, Brent A Appleton, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors
Young Shin Cho, Hayley Angove, Christopher Brain, et al.
Page
of 4